Recent data indicate an expanding role for nextgeneration oral SERDs in adjuvant treatment for ERpositiveHER2negative early breast cancer Join us for this dynamic live symposium in which an expert panel will provide education on this topic via highly interactive game showstyle sessions and learnerled Experts in the Hot Seat panel discussions Sign up now
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 12001 Sunrise Valley Drive
Pricing
98% of listed courses are free
294 of a sample of 300 are free · 531 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Conference / congress
- Credit · Up to 1.5 credits
- MOC · Up to 1.5 points
- Commercial Support
-
WhenDec 8, 2026
-
Med Learning Group Emerging Oral SERDs in Early HR+/HER2- Breast Cancer: Biomarkers, Shared Decision-Making, and Practical Management of Investigational Therapies
-
Answers in CME Inc. (AiCME) Integrating ESR1m Testing and Novel Oral SERDS Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer
-
PRIME Education, Inc. (PRIME®) Clinical Evidence at the Edge of Resistance: Next-Generation SERDs for ESR1-Mutated Breast Cancer
-
Clinical Care Options, LLC (dba Decera Clinical Education) Beyond Resistance: Integrating Next-Generation SERDs Into Community Management of ER-Positive/HER2-Negative Advanced Breast Cancer
-
Clinical Care Options, LLC (dba Decera Clinical Education) Integrating HER2-Directed ADCs Across Early and Metastatic Breast Cancer: Practical Strategies for Testing, Sequencing, and Patient-Centered Care
-
Clinical Care Options, LLC (dba Decera Clinical Education) Evolving Treatment Landscape for High-Risk HR-Positive/HER2-Negative EBC With and Without gBRCAm
